Hyperglycemia and Adverse Pregnancy Outcomes

By J. Dungan. 2009

3,049 citations recorded by the source corpus.

Subfields: Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/aba9aa62028ed4c50847951d199422cffa5fdf77

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Obstetrics and Gynecology

1. V. Basevi
2. M. Schmidt
3. E. Wendland
4. M. Agarwal
5. M. A. Campos
6. T. Buchanan
7. D. Sacks
8. B. Duncan

In Pediatrics, Perinatology and Child Health

1. M. Schmidt
2. E. Wendland
3. M. Agarwal
4. M. A. Campos
5. T. Buchanan
6. D. Sacks
7. B. Duncan
8. H. Mcintyre

Citations in the corpus

• Cellular and molecular mechanisms of metformin: an overview. (2012, background): “18 The risk of gestational diabetes (GD) is increasing in obese women and is associated with adverse pregnancy outcomes [143].”
• Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). (2006, background): “The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study (13), a large-scale (;25,000 pregnant women) multinational epidemiologic study, demonstrated that risk of adverse maternal, fetal, and neonatal outcomes continuously increased as a function of maternal glycemia at 24–28 weeks, even within”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “Strong associations were also found with infant adiposity (177), with some secondary outcomes (including risks of shoulder dystocia and/or birth injury), and with preeclampsia (176).”
• The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care # (2015, methodology): “Another study, based on the Gestational Diabetes Formulas for CostEffectiveness or GeDiForCE Model [35] described in Appendix 2, showed that the interventions are “highly cost-effective” in both Indian and Israeli settings when long-term effects are taken into account [36].”
• Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria (2012, methodology): “Included studies Data on the adverse outcomes associated with diagnostic criteria were extracted from 8 studies (9 publications) [7,12-19], all of which were published in full in peer reviewed journals (Table 1).”
• Diagnosis and Classification of Diabetes Mellitus (2011, background): “Results of the Hyperglycemia and Adverse Pregnancy Outcomes study (13), a large-scale ( 25,000 pregnant women) multinational epidemiologic study, demonstrated that risk of adverse maternal, fetal, and neonatal outcomes continuously increased as a function of maternal glycemia at 24 –28 weeks, even w”
• Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. (2014, methodology): “The most comprehensive study is the HAPO study, an international multicentre cohort of 25,505 pregnant women tested with a 2-h 75 g OGTT and then followed through pregnancy to detect primary and secondary outcomes [26].”